Literature DB >> 19908162

Soluble components of Histoplasma capsulatum var. capsulatum have hemagglutinin activity and induce syngeneic hemophagocytosis in vitro.

R H F Vivan1, P C Leonello, L A Nagashima, M S Kaminami, F S M Tristão, A Sano, M A Ono, C V Béjar, E N Itano.   

Abstract

Histoplasma capsulatum var. capsulatum is a thermally dimorphic fungus that causes histoplasmosis. Fungal hemagglutination activity and cases of reactive hemophagocytic syndrome (RHS) have been reported in the disseminated form of disease. In the present study, soluble components of H. capsulatum var. capsulatum have been investigated for hemagglutinin activity and the capacity to induce hemophagocytosis in the mouse system. To analyze hemagglutinating activity, mouse red blood cells (RBC) (1% v/v in PBS) were incubated (37 degrees C, 1 h) with cell-free antigen (CFAg) from H. capsulatum var. capsulatum (isolate IMT/HC128) (RBC-CFAg) or previously heated CFAg (56 degrees C, 30 min) (RBC-hCFAg) or as control with PBS (RBC-PBS). Hemophagocytosis was analyzed by incubating BALB/c mouse peritoneal phagocytic cells (5 x 10(6) cells) with syngeneic RBC, sensitized or not with CFAg. In addition, mouse polyclonal antibodies were raised against syngeneic RBC-CFAg (anti-RBC-CFAg) and used to analyze CFAg chromatographic fractions (Sephadex G75/120) by immunoenzymatic assay (ELISA). Hemagglutinin activity was observed with RBC-CFAg, but not with RBC-hCFAg or RBC. Also, hemophagocytosis was observed with RBC-CFAg, but not with RBC. The anti-RBC-CFAg antibodies reacted with CFAg fractions corresponding to a molecular mass (MM) higher than 150 kDa. In conclusion, the yeast form of H. capsulatum var. capsulatum releases thermolabile soluble components with hemagglutinin activity and it has been demonstrated for the first time that soluble components of the same fungus induce syngeneic hemophagocytosis in the in vitro mouse system. Also, indirect analysis with antibodies suggests that high-MM components (>150 kDa) are responsible for the interaction with RBC.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19908162     DOI: 10.1007/s11046-009-9243-3

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  22 in total

1.  Clearance of fungal burden during treatment of disseminated histoplasmosis with liposomal amphotericin B versus itraconazole.

Authors:  L J Wheat; G Cloud; P C Johnson; P Connolly; M Goldman; A Le Monte; D E Fuller; T E Davis; R Hafner
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

2.  Comparison of radioimmunoassay and enzyme-linked immunoassay methods for detection of Histoplasma capsulatum var. capsulatum antigen.

Authors:  M M Durkin; P A Connolly; L J Wheat
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

3.  A case study of disseminated histoplasmosis linked to common variable immunodeficiency.

Authors:  Acir Rachid; Lucila Stange Rezende; Suzelle Freitas de Moura; Paulo C Loffy; Francisco Luiz Gomide M Magalhães
Journal:  Braz J Infect Dis       Date:  2003-08       Impact factor: 1.949

4.  Familial and acquired hemophagocytic lymphohistiocytosis.

Authors:  Gritta Janka; Udo zur Stadt
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2005

5.  Histoplasmosis in a Brazilian center: clinical forms and laboratory tests.

Authors:  Beatriz Consuelo Quinet Leimann; Cláudia Vera Pizzini; Mauro Medeiros Muniz; Priscila Carvalho Albuquerque; Paulo Cezar Fialho Monteiro; Rosani Santos Reis; Rodrigo Almeida-Paes; Márcia Santos Lazera; Bodo Wanke; Maurício Andrade Pérez; Rosely Maria Zancopé-Oliveira
Journal:  Rev Iberoam Micol       Date:  2005-09       Impact factor: 1.044

Review 6.  Infection- and malignancy-associated hemophagocytic syndromes. Secondary hemophagocytic lymphohistiocytosis.

Authors:  G Janka; S Imashuku; G Elinder; M Schneider; J I Henter
Journal:  Hematol Oncol Clin North Am       Date:  1998-04       Impact factor: 3.722

7.  Efficacy of cell-free antigens in evaluating cell immunity and inducing protection in a murine model of histoplasmosis.

Authors:  Anderson Sá-Nunes; Alexandra I Medeiros; Roberto Nicolete; Fabiani G Frantz; Ademilson Panunto-Castelo; Célio L Silva; Lúcia H Faccioli
Journal:  Microbes Infect       Date:  2005-03-14       Impact factor: 2.700

8.  Inflammatory cytokines in virus-associated hemophagocytic syndrome. Interferon-gamma as a sensitive indicator of disease activity.

Authors:  S Ohga; A Matsuzaki; M Nishizaki; T Nagashima; T Kai; M Suda; K Ueda
Journal:  Am J Pediatr Hematol Oncol       Date:  1993-08

9.  Histoplasma capsulatum yeast cells attach and agglutinate human erythrocytes.

Authors:  M L Taylor; E Duarte-Escalante; A Pérez; E Zenteno; C Toriello
Journal:  Med Mycol       Date:  2004-06       Impact factor: 4.076

Review 10.  Hemophagocytic syndromes and infection.

Authors:  D N Fisman
Journal:  Emerg Infect Dis       Date:  2000 Nov-Dec       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.